[go: up one dir, main page]

WO2007039781A3 - 1,2,4-oxadioi.e derivatives with activity at the metabotropic clutamate receptors - Google Patents

1,2,4-oxadioi.e derivatives with activity at the metabotropic clutamate receptors Download PDF

Info

Publication number
WO2007039781A3
WO2007039781A3 PCT/HU2006/000087 HU2006000087W WO2007039781A3 WO 2007039781 A3 WO2007039781 A3 WO 2007039781A3 HU 2006000087 W HU2006000087 W HU 2006000087W WO 2007039781 A3 WO2007039781 A3 WO 2007039781A3
Authority
WO
WIPO (PCT)
Prior art keywords
group
alkyl
compounds
oxadioi
clutamate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/HU2006/000087
Other languages
French (fr)
Other versions
WO2007039781A2 (en
Inventor
Krisztina GÁL
Csaba WÉBER
Gábor András WÁGNER
Attila HORVÁTH
Györgyné NYÉKI
Mónika VASTAG
György KESERÜ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of WO2007039781A2 publication Critical patent/WO2007039781A2/en
Anticipated expiration legal-status Critical
Publication of WO2007039781A3 publication Critical patent/WO2007039781A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The present invention relates to new compounds of formula (I) wherein Y1 and Y2 selected from the group consisting of hydrogen, halogen atom; C1-4 alkyl, C1-4 alkoxy, cyano and trifluoromethyl group, Q is -CH- group or N; X1 and X2 are different and are independently selected from N and O; Z is -(CH2)n- group or S; n is 1 or 2; R is selected from the group consisting of optionally substituted C1-7 alkyl, C1-4 haloalkyl, C1-4 hydroxyalkyl, C1-4 cyanoalkyl, C1-3 OC1-3 alkyl, C2-7 alkenyl, C2-7 alkynyl, C0-2(NR1R2)alkyl; an optionally substituted C3-7 cycloalkyl, aryl, heteroaryl or saturated heterocyclyl; R1 and R2 are independently selected from hydrogen, C1-7 alkyl or C1-6 alkanoyl group - and/or enentiomers and/or racemates and/or diastereomers and/or geometric isomers and/or pharmaceutically acceptable salts thereof formed with acids and bases, to the processes for producing said compounds, to pharmaceutical compositions containing said compounds and to their use in the prevention and/or treatment of mGluR5 receptor-mediated disorders.
PCT/HU2006/000087 2005-10-05 2006-10-05 New compounds Ceased WO2007039781A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0500920A HUP0500920A2 (en) 2005-10-05 2005-10-05 Oxadiazole derivatives, process for their preparation and their use
HUP0500920 2005-10-05

Publications (2)

Publication Number Publication Date
WO2007039781A2 WO2007039781A2 (en) 2007-04-12
WO2007039781A3 true WO2007039781A3 (en) 2010-08-26

Family

ID=89986317

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/HU2006/000087 Ceased WO2007039781A2 (en) 2005-10-05 2006-10-05 New compounds

Country Status (2)

Country Link
HU (1) HUP0500920A2 (en)
WO (1) WO2007039781A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2672616A1 (en) 2006-12-15 2008-06-26 Abbott Laboratories Novel oxadiazole compounds
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
CA2758731A1 (en) * 2009-04-23 2010-10-28 Merck Sharp & Dohme Corp. 2-alkyl piperidine mglur5 receptor modulators
CA2808582A1 (en) 2009-08-14 2011-02-17 University Of Virginia Patent Foundation Imidamide sphingosine kinase inhibitors
WO2011082010A1 (en) * 2009-12-29 2011-07-07 Eli Lilly And Company Tetrahydrotriazolopyridine compounds as selective mglu5 receptor potentiators useful for the treatment of schizophrenia
JP2013518085A (en) 2010-02-01 2013-05-20 ノバルティス アーゲー Pyrazolo [5,1b] oxazole derivatives as CRF-1 receptor antagonists
WO2011092293A2 (en) 2010-02-01 2011-08-04 Novartis Ag Cyclohexyl amide derivatives as crf receptor antagonists
CN102753527B (en) 2010-02-02 2014-12-24 诺华股份有限公司 Cyclohexyl amide derivatives as crf receptor antagonists
CN103313977B (en) * 2010-10-21 2015-06-03 拜耳知识产权有限责任公司 1-(Heterocyclic carbonyl)piperidine
AR091257A1 (en) 2012-06-04 2015-01-21 Actelion Pharmaceuticals Ltd BENCIMIDAZOL-PROLINA DERIVATIVES
EA201500399A1 (en) 2012-10-10 2015-09-30 Актелион Фармасьютиклз Лтд. OREXIN RECEPTOR ANTAGONISTS, WHICH ARE REPRESENTING DERIVATIVES OF [ORTO-BI- (HETERO) ARYL] - [2- (META-BI- (HETERO) ARYL) PYRROLIDIN-1-IL] METHANON
EP2970241A1 (en) 2013-03-12 2016-01-20 Actelion Pharmaceuticals Ltd. Azetidine amide derivatives as orexin receptor antagonists
DK3077391T3 (en) 2013-12-04 2018-10-22 Idorsia Pharmaceuticals Ltd USE OF BENZIMIDAZOLE PROLINE DERIVATIVES
EP3914592A1 (en) * 2019-01-25 2021-12-01 University of Virginia Patent Foundation Inhibitors of spinster homolog 2 (spns2) for use in therapy
KR20220085798A (en) * 2019-10-17 2022-06-22 지보당 에스아 Substituted azacycles as TRMP8 modulators
GB202012170D0 (en) * 2020-08-05 2020-09-16 Givaudan Sa Organic compounds
EP4210824A1 (en) * 2020-09-09 2023-07-19 University of Virginia Patent Foundation Inhibitors of spinster homolog 2 (spns2) for use in therapy

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998017652A1 (en) * 1996-10-18 1998-04-30 Boehringer Ingelheim Pharma Kg Oxadiazoles, processes for their preparation and their use as medicaments
WO2000039125A1 (en) * 1998-12-23 2000-07-06 Pfizer Limited Piperidines as ccr5 modulators
WO2002092086A1 (en) * 2001-03-27 2002-11-21 F. Hoffmann-La Roche Ag Imidazo (1,2-a)-pyridine derivatives as mglur5 antagonists
WO2004014902A2 (en) * 2002-08-09 2004-02-19 Astrazeneca Ab Compounds having an activity at metabotropic glutamate receptors
WO2005044797A1 (en) * 2003-11-06 2005-05-19 Addex Pharmaceuticals Sa Allosteric modulators of metabotropic glutamate receptors

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998017652A1 (en) * 1996-10-18 1998-04-30 Boehringer Ingelheim Pharma Kg Oxadiazoles, processes for their preparation and their use as medicaments
WO2000039125A1 (en) * 1998-12-23 2000-07-06 Pfizer Limited Piperidines as ccr5 modulators
WO2002092086A1 (en) * 2001-03-27 2002-11-21 F. Hoffmann-La Roche Ag Imidazo (1,2-a)-pyridine derivatives as mglur5 antagonists
WO2004014902A2 (en) * 2002-08-09 2004-02-19 Astrazeneca Ab Compounds having an activity at metabotropic glutamate receptors
WO2005044797A1 (en) * 2003-11-06 2005-05-19 Addex Pharmaceuticals Sa Allosteric modulators of metabotropic glutamate receptors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BING YAN ET AL.: "Quality control on combinatorial chemistry:", JOURNAL OF COMBINATORIAL CHEMISTRY, vol. 5, no. 5, 2003, pages 547 - 559, XP002413033 *

Also Published As

Publication number Publication date
HU0500920D0 (en) 2005-12-28
WO2007039781A2 (en) 2007-04-12
HUP0500920A2 (en) 2007-07-30

Similar Documents

Publication Publication Date Title
WO2007039781A3 (en) 1,2,4-oxadioi.e derivatives with activity at the metabotropic clutamate receptors
HRP20140975T1 (en) N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors
EP1857457A3 (en) Benzimidazole derivative and its use as AII receptor antagonist
MXPA04009784A (en) Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors.
RU2010126105A (en) Pyridine derivatives substituted by a heterocyclic ring and a phosphonoxymethyl group and containing antifungal agents
NO20091590L (en) Heterocyclic amide compounds useful as kinase inhibitors
CA2523261A1 (en) Fused pyrimidine derivatives with crf activity
JP2008526999A5 (en)
HRP20070430T3 (en) (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
ATE431345T1 (en) AZABICYCLO-(3,1,0)-HEXANE DERIVATIVES SUITABLE AS MODULATORS OF DOPAMINE D3 RECEPTORS
MX2009010790A (en) Fused bicyclic heteroaryl derivatives.
RU2008112691A (en) NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ITS PHARMACEUTICAL APPLICATION
WO2004089366A8 (en) Bicyclic compounds as nr2b receptor antagonists
PH12012500867A1 (en) Ethynyl derivatives
NO20076060L (en) Piperidin-4-yl amide derivatives and their use as SST receptor subtype 5 antagonists
DE602004031722D1 (en) CONDENSED BICYCLIC SUBSTITUTED AMINE AS HISTAMIN 3 RECEPTOR LIGANDS
EA200300071A1 (en) THERAPEUTIC PREPARATION FOR THE TREATMENT OF FEAR NEUROSIS (ALARM) OR DEPRESSIONS AND DERIVATIVES OF PIPERAZINE
JP2015502371A5 (en)
PE20061156A1 (en) BENZAMIDE DERIVATIVES AS INHIBITING AGENTS OF THE GLYCINE TRANSPORTER
NO20072060L (en) 2 acylaminotiazolderivater
MX2009002905A (en) 3 -amino- pyridine derivatives for the treatment of metabolic disorders.
MXPA02011464A (en) 1,4 diazepan 2,5 dione derivatives and their use as nk 1 receptor antagonists.
ATE479690T1 (en) THIENOÄ2,3-BÜPYRIDINE DERIVATIVES
NO20070972L (en) Benzyloxy derivatives as MAOB inhibitors
AR045548A1 (en) IMIDAZOL DERIVATIVES

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06795045

Country of ref document: EP

Kind code of ref document: A2